Browsing: Cutaneous

Another RELATIVITY trial demonstrates the promise of adding the LAG-3 inhibitor relatlimab to nivolumab for metastatic melanoma, not only upfront,…

  January 03, 2023 Comeback. This huge meta-analysis including more than 125K patients with cutaneous squamous cell carcinoma reports the…

December 13, 2022 Brisket. This retrospective look at 142 cases of metastatic melanoma treated with immune checkpoint inhibition with available…

In case you’re not convinced, another retrospective study, this one looking at 203 patients receiving radiosurgery for 1388 melanoma brain…

The SECOMBIT trial demonstrated relative good outcomes with any sequencing of combo ipilimumab/nivolumab and dual BRAF/MEK inhibition for metastatic BRAF-mutated…

We have sad news for our fellow Southerners out there with Northern-European ancestry who filled their childhood summers with care-free…

There are no official recommendations for melanoma screening among the general population, as no strategy has proven worthwhile. The University…